World's Best Scientists 2026 revealed!
Award Badge
Medicine
Spain
2023
Award Badge
Microbiology
Spain
2022

D-Index & Metrics

Biology and Biochemistry

D-Index
102
Citations
53292
World Ranking
1339
National Ranking
15

Medicine

D-Index
102
Citations
54605
World Ranking
7520
National Ranking
108

Research.com Recognitions

  • 2023 - Research.com Medicine in Spain Leader Award
  • 2022 - Research.com Microbiology in Spain Leader Award

Overview

Maria Buti is affiliated with the Instituto de Salud Carlos III in Spain and has a significant body of work in the field of medicine, with a focus on epidemiology and hepatology. Their research contributions span topics related to liver diseases, infectious diseases, and oncology.

The scientist has published extensively on hepatitis viruses and liver disease diagnosis and treatment, with key thematic areas including:

  • Hepatitis C virus research
  • Hepatitis B virus studies
  • Liver disease diagnosis and treatment
  • Hepatitis viruses studies and epidemiology
  • Liver disease and transplantation
  • HIV/AIDS drug development and treatment
  • HIV, drug use, sexual risk

Prominent publication venues for their work include:

  • Journal of Hepatology
  • JHEP Reports
  • Alimentary Pharmacology & Therapeutics
  • Liver International
  • Clinical Gastroenterology and Hepatology

Frequent coauthors associated with Maria Buti are:

  • Rafael Esteban
  • Ariadna Rando-Segura
  • Mar Riveiro-Barciela
  • Adriana Palom
  • Pietro Lampertico

Selected recent papers illustrate the scope and focus of their research:

  • Genomewide Association Study of Severe Covid-19 with Respiratory Failure, 2020, New England Journal of Medicine
  • Advancing the global public health agenda for NAFLD: a consensus statement, 2021, Nature Reviews Gastroenterology & Hepatology
  • Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study, 2022, The Lancet. Gastroenterology & Hepatology
  • aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis, 2020, Journal of Hepatology
  • EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients, 2021, Journal of Hepatology

Best Publications

  • EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.

    Pietro Lampertico;Kosh Agarwal;Thomas Berg;Maria Buti

  • Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

    Nezam Afdhal;Stefan Zeuzem;Paul Kwo;Mario Chojkier

  • Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

    Patrick Marcellin;Edward J Gane;Maria Buti;Nezam H Afdhal

  • Genomewide Association Study of Severe Covid-19 with Respiratory Failure.

    David Ellinghaus;Frauke Degenhardt;Luis Bujanda;Maria Buti

  • Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

    Devin Razavi-Shearer;Ivane Gamkrelidze;Mindie H Nguyen;Ding-Shinn Chen

  • Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B

    Patrick Marcellin;E Jenny Heathcote;Maria Buti;Ed Gane

  • Hepatitis C virus antibodies among risk groups in Spain.

    J.I. Esteban;L. Viladomiu;A. Gonzalez;M. Roget

  • Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group.

    Tassopoulos Nc;Volpes R;Pastore G;Heathcote J

  • Advancing the global public health agenda for NAFLD: a consensus statement.

    Jeffrey V Lazarus;Henry E Mark;Quentin M Anstee;Juan Pablo Arab

  • Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia.

    Stefan Zeuzem;Maria Buti;Peter Ferenci;Jan Sperl

  • Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B

    E. Jenny Heathcote;Patrick Marcellin;Maria Buti;Edward Gane

  • A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.

    Markus Cornberg;Homie A. Razavi;Alfredo Alberti;Enos Bernasconi

  • Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

    Michael Manns;Didier Samuel;Edward J Gane;David Mutimer

  • Hepatitis C virus infection

    Michael P. Manns;Maria Buti;Ed Gane;Jean-Michel Pawlotsky;Jean-Michel Pawlotsky

  • PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

    George Papatheodoridis;George Dalekos;Vana Sypsa;Cihan Yurdaydin

  • Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial

    Michael Manns;Patrick Marcellin;Fred Poordad;Evaldo Stanislau Affonso de Araujo

  • Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

    Maria Buti;Edward Gane;Wai Kay Seto;Henry L.Y. Chan

  • Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease.

    Yun-Fan Liaw;I-Shyan Sheen;Chuan-Mo Lee;Ulus Salih Akarca

  • Historical epidemiology of hepatitis C virus (HCV) in selected countries

    P. Bruggmann;T. Berg;A. L. H. Øvrehus;C. Moreno

  • Hepatitis E virus epidemiology in industrialized countries.

    Pilar Clemente-Casares;Sonia Pina;Maria Buti;Rosend Jardi

Frequent Co-Authors

Rafael Esteban
Rafael Esteban Vall d'Hebron Hospital Universitari
Harry L.A. Janssen
Harry L.A. Janssen Erasmus University Rotterdam
Patrick Marcellin
Patrick Marcellin Université Paris Cité
Stefan Zeuzem
Stefan Zeuzem Goethe University Frankfurt
George V. Papatheodoridis
George V. Papatheodoridis National and Kapodistrian University of Athens
Juan Ignacio Esteban
Juan Ignacio Esteban Vall d'Hebron Hospital Universitari
Pietro Lampertico
Pietro Lampertico University of Milan
Javier García-Samaniego
Javier García-Samaniego Hospital Universitario La Paz
Henry Lik-Yuen Chan
Henry Lik-Yuen Chan Chinese University of Hong Kong

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students interested in Biology and Biochemistry often pursue advanced degrees in healthcare and science-related fields. Many leading universities now offer flexible online options that let you further your education while managing work or other obligations.

For those aiming for leadership in healthcare, you might consider cahme-accredited online mha programs. These programs provide training in healthcare administration and are recognized for meeting rigorous academic standards.

If you see yourself in nursing leadership roles, there are dnp online no clinicals options. They offer a path to a Doctor of Nursing Practice without the need for additional clinical hours, ideal for working professionals.

Those interested in research and academic careers may look into earning a phd in healthcare management online to develop expertise in healthcare systems and policy.

Furthermore, students passionate about drug development and patient care might explore online pharmacy school options, opening doors to various pharmacy and pharmaceutical roles.

Best Scientists Citing Maria Buti

Trending Scientists